Celyad Oncology SA

€0.18As of Sun 8 Nov 2026, 12:00 UTC
EBR:CYADHealthcare
Country Belgium
PE (Fwd) •••
TSR 10Y CAGR (36.00%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.23
PE TTM 2.587
TSR TTM (11.44%)
Mkt cap €7.968M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.201
13.04%
158.65%
Hold 10|4|1|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per share€
—
—
—
—
24.55%
20.02%
19.78%
12.33%
Revenue€M
0.670
0.709
0.709
0.714
(1.89%)
5.84%
0.20%
3.67%
Peers (US$8.946M)
Cap (US$)
PE
16.16M
7.436x
14.98M
—
1.256M
—
8.978M
0.408x
Capital
TTM
5Y
10Y
Leveragex
1.359
(1.378)
(1.076)
EBIT/Intx
4.028
0.555
0.656
Own earn%
102.47
(15.29)
(9.92)
Sh yield%
57.48
40.96
40.61
Owners
Insiders/Inst%
6.07
46.85
Short interest%
3.44
SBC / revenue%
1.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
28–36
$1 testx
0.1
Incr. ROIC%
28